NAME Dr Jenny Y. Wang CANCER TYPE Leukaemia INSTITUTION University of New South Wales, CCI STATE New South Wales GRANT TYPE $200,000 PROJECT TYPE Research
Targeting self-renewal pathways for the development of a curative therapy in aggressive leukaemia
"In this study, we will validate a recently-developed therapeutic antibody that specifically targets the R-spondin pathway critical for Leukaemia stem cellssurvival. This preclinical evidence is essential for drug testing that will enable the development of future clinical studies for the treatment of leukaemia with poor prognosis and to improve the dismal outcome of acute myeloid leukaemia."
- University of New South Wales, Children's Cancer Institute